Brain injury risk from primary blast.

Published

Journal Article

BACKGROUND: Military service members are often exposed to at least one explosive event, and many blast-exposed veterans present with symptoms of traumatic brain injury. However, there is little information on the intensity and duration of blast necessary to cause brain injury. METHODS: Varying intensity shock tube blasts were focused on the head of anesthetized ferrets, whose thorax and abdomen were protected. Injury evaluations included physiologic consequences, gross necropsy, and histologic diagnosis. The resulting apnea, meningeal bleeding, and fatality were analyzed using logistic regressions to determine injury risk functions. RESULTS: Increasing severity of blast exposure demonstrated increasing apnea immediately after the blast. Gross necropsy revealed hemorrhages, frequently near the brain stem, at the highest blast intensities. Apnea, bleeding, and fatality risk functions from blast exposure to the head were determined for peak overpressure and positive-phase duration. The 50% risk of apnea and moderate hemorrhage were similar, whereas the 50% risk of mild hemorrhage was independent of duration and required lower overpressures (144 kPa). Another fatality risk function was determined with existing data for scaled positive-phase durations from 1 millisecond to 20 milliseconds. CONCLUSION: The first primary blast brain injury risk assessments for mild and moderate/severe injuries in a gyrencephalic animal model were determined. The blast level needed to cause a mild/moderate brain injury may be similar to or less than that needed for pulmonary injury. The risk functions can be used in future research for blast brain injury by providing realistic injury risks to guide the design of protection or evaluate injury.

Full Text

Cited Authors

  • Rafaels, KA; Bass, CRD; Panzer, MB; Salzar, RS; Woods, WA; Feldman, SH; Walilko, T; Kent, RW; Capehart, BP; Foster, JB; Derkunt, B; Toman, A

Published Date

  • October 2012

Published In

Volume / Issue

  • 73 / 4

Start / End Page

  • 895 - 901

PubMed ID

  • 22836001

Pubmed Central ID

  • 22836001

Electronic International Standard Serial Number (EISSN)

  • 2163-0763

International Standard Serial Number (ISSN)

  • 2163-0755

Digital Object Identifier (DOI)

  • 10.1097/ta.0b013e31825a760e

Language

  • eng